Compare ELTX & XHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
XChange Tec Inc formerly FLJ Group Ltd is engaged in providing an apartment rental platform in China. The company leases apartments from landlords and transforms these apartments, into standardized furnished rooms to lease to people seeking residence in cities. It cooperates with third parties, including professional home service providers, e-commerce companies and other service providers to facilitate value-added services for its tenants.